HESI

  

 

 

 

Home Page

MEMBER LOGIN

Not registered?
Register here!

CONTACT US

by email:
hesi@hesiglobal.org

by phone:
202-659-3306 tel
202-659-3617 fax

by mail:
One Thomas Circle, NW
9th Floor
Washington, DC 20005-5802
USA



To connect to the
ILSI home page
click here.

HESI Activities at the March 2008 Society of Toxicology Annual Meeting

Please see below the list of HESI committee-sponsored programs at this year's Annual Meeting of the Society of Toxicology at the Washington State Convention and Trade Center in Seattle , Washington , USA .  We encourage you to attend one or more of the following to learn about these HESI activities.  Be sure to visit the HESI booth in the Exhibition Hall to talk with HESI Board members and staff.  More information about the March 17-19, 2008 meeting can be found on the SOT website at http://www.toxicology.org/AI/MEET/AM2008/index.asp .

           

·        HESI Booth, SOT ToxExpo:  #535.

 

·        Monday, March 17.  Roundtable Session.  4:30 PM-5:50 PM.  “Immunotoxicity Testing: Should Elevated Antibody Responses Be Interpreted as an Indicator of Immunotoxicological Hazard?”  HESI Immunotoxicology Technical Committee.  Session Co-Chair, Michael Holsapple (HESI).  Room 615CC.

 

·        Monday, March 17.  HESI-sponsored luncheon seminar.  12:00 PM – 1:00 PM.  “EPA's ToxCast Program:  Developing Predictive Bioactivity Signatures for Chemicals.” Inaugural Speaker:  Robert Kavlock (EPA/NCTR).

 

·     Wednesday, March 19.  Poster Presentation. 9:00 am. “Cytotoxicity of Nanosized TiO2 and multi-walled carbon nanotubes on cell proliferation in vitro.  J. Gibson.  Poster Board 313.

 

·        Wednesday, March 19.  Poster Presentation.  1:00 PM.   “Comparative Performance of Novel Markers of Nephrotoxicity in the Rat.”  E. Harpur; K. Schuster; G. Betton; D. Bounous; D. Ennulat; B. Reifke; L. Mylecraine; D. Hoffman; J. Gautier; S. Beushausen; S. Pettit. Poster Board 232.

 

·        Wednesday, March 19.  Poster Presentation. 1:00 PM.  “Diagnostic Criteria for Selected Peroxisome Proliferator-Activated Receptor (PPAR) Agonist-Induced Mesenchymal Lesions in the Rat.”  Presentation on behalf of the HESI PPAR Agonist Project Committee by Jerry Hardisty (Experimental Pathology Laboratories, Inc.). Poster Board 552.

 

·        Wednesday, March 19.  Poster Presentation. 1:00 PM.  “Diagnostic Criteria for Selected Peroxisome Proliferator-Activated Receptor (PPAR) Agonist-Induced Vascular Lesions in the Mouse.” Presentation on behalf of the HESI PPAR Agonist Project Committee by Jerry Hardisty (Experimental Pathology Laboratories, Inc.). Poster Board 553.

 

 

Please contact any member of the HESI staff if you have questions.  We look forward to seeing you in Seattle!